Literature DB >> 19724752

Clozapine-induced bowel infarction: a case report.

Nicholas D McKinnon1, Alvi Azad, Brian M Waters, Kaustubh G Joshi.   

Abstract

Resistant schizophrenia is often treated with clozapine after other conventional atypical antipsychotics have failed or have resulted in intolerable side effects. Clozapine is generally reserved for secondary use due to its propensity to cause serious side effects, such as life-threatening agranulocytosis and the necessity for life-long blood monitoring. In this case report we present a 40-year-old female patient who suffered from chronic constipation and bowel infarctions after long-term use with clozapine. Although the use of this medication resulted in multiple abdominal surgeries with subtotal colonic resections, the patient's schizophrenic symptoms only responded to clozapine after several repeat failures with other medications; ultimately, she was continued on this medication.

Entities:  

Keywords:  atypical antipsychotic; bowel surgery; clozapine; constipation; ischemic colitis; schizoaffective disorder

Year:  2009        PMID: 19724752      PMCID: PMC2719458     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  32 in total

1.  Clozapine-associated postoperative ileus: case report and review of the literature.

Authors:  B Erickson; D M Morris; A Reeve
Journal:  Arch Gen Psychiatry       Date:  1995-06

2.  Management of clozapine-induced enuresis.

Authors:  J S Aronowitz; A Z Safferman; J A Lieberman
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

3.  A case report of clozapine-induced gastric outlet obstruction.

Authors:  B J Schwartz; J A Frisolone
Journal:  Am J Psychiatry       Date:  1993-10       Impact factor: 18.112

4.  Clozapine-induced tardive dyskinesia: a case report.

Authors:  Aygun Ertugrul; Basaran Demir
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-05       Impact factor: 5.067

5.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

Review 6.  Drug interactions with smoking.

Authors:  Lisa A Kroon
Journal:  Am J Health Syst Pharm       Date:  2007-09-15       Impact factor: 2.637

Review 7.  Update on the clinical efficacy and side effects of clozapine.

Authors:  A Safferman; J A Lieberman; J M Kane; S Szymanski; B Kinon
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

Review 8.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Three case reports of emergent dyskinesia with clozapine.

Authors:  Rafael Gafoor; Justin Brophy
Journal:  Eur Psychiatry       Date:  2003-08       Impact factor: 5.361

10.  Case report: rapidly fatal bowel ischaemia on clozapine treatment.

Authors:  Giles Townsend; David Curtis
Journal:  BMC Psychiatry       Date:  2006-10-19       Impact factor: 3.630

View more
  4 in total

Review 1.  Drug-induced gastrointestinal disorders.

Authors:  H L Philpott; S Nandurkar; J Lubel; P R Gibson
Journal:  Frontline Gastroenterol       Date:  2013-06-19

2.  Risk factors for ileus in patients with schizophrenia.

Authors:  Jimmi Nielsen; Jonathan M Meyer
Journal:  Schizophr Bull       Date:  2010-11-26       Impact factor: 9.306

3.  Clozapine-induced ischaemic colitis.

Authors:  Veer Shah; Jacqueline Anderson
Journal:  BMJ Case Rep       Date:  2013-01-22

4.  Medication-induced acute esophageal necrosis: a case report.

Authors:  Lauri Pautola; Tapio Hakala
Journal:  J Med Case Rep       Date:  2016-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.